Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: A prospective, cross-sectional, multicenter study

Journal of Clinical Oncology

Volumn 32, Issue 17, 2014, Pages 1792-1796

  Zwicker, Jeffrey I ^a   Rojan, Adam ^a   Campigotto, Federico ^b   Rehman, Nadia ^c,d   Funches, Renee ^a   Connolly, Gregory ^e   Webster, Jonathan ^f   Aggarwal, Anita ^g   Mobarek, Dalia ^g   Faselis, Charles ^g   Neuberg, Donna ^b   Rickles, Frederick R ^g   Wun, Ted ^c,d   Streiff, Michael B ^f   Khorana, Alok A ^h  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

^h TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; HEPARIN;

ACUTE RESPIRATORY FAILURE; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BODY MASS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER THERAPY; CROSS-SECTIONAL STUDY; FEMALE; HEMATOLOGIC MALIGNANCY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MULTICENTER STUDY; NAUSEA; PADUA SCORING SYSTEM; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SOLID TUMOR; THROMBOSIS; THROMBOSIS PREVENTION; UNIVERSITY HOSPITAL; VENOUS THROMBOEMBOLISM; VOMITING;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; THROMBOEMBOLISM; YOUNG ADULT;

EID: 84905851624     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.53.5336     Document Type: Article

References (21)

1. Khorana AA: Cancer and thrombosis: Implications of published guidelines for clinical practice. Ann Oncol 20:1619-1630, 2009
2. Petersen LJ: Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: A review of current guidelines. Cancer Treat Rev 35:754-764, 2009
3. Lyman GH, Khorana AA, Falanga A, et al: American Society of Clinical Oncology guideline: Recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 25:5490-5505, 2007 (Pubitemid 350232226)
4. Kahn SR, Lim W, Dunn AS, et al: Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed - American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e195S-e226S, 2012
5. National Comprehensive Cancer Network: Clinical practice guidelines in venous thromboembolic disease. http://www.nccn.org/professionals/physician-gls/ f-guidelines.asp
6. Burleigh E, Wang C, Foster D, et al: Thromboprophylaxis in medically ill patients at risk for venous thromboembolism. Am J Health Syst Pharm 63:S23-S29, 2006 (Pubitemid 44672126)
7. Barbar S, Noventa F, Rossetto V, et al: A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: The Padua Prediction Score. J Thromb Haemost 8:2450-2457, 2010
8. Lyman GH: Thromboprophylaxis with low-molecular-weight heparin in medical patients with cancer. Cancer 115:5637-5650, 2009
9. Amin A, Stemkowski S, Lin J, et al: Thromboprophylaxis rates in US medical centers: Success or failure? J Thromb Haemost 5:1610-1616, 2007 (Pubitemid 47091400)
10. Seddighzadeh A, Shetty R, Goldhaber SZ: Venous thromboembolism in patients with active cancer. Thromb Haemost 98:656-661, 2007 (Pubitemid 47412893)
11. Amin AN, Varker H, Princic N, et al: Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patients. J Hosp Med 7:231-238, 2012
12. Amin AN, Stemkowski S, Lin J, et al: Inpatient thromboprophylaxis use in U.S. hospitals: Adherence to the seventh American College of Chest Physician's recommendations for at-risk medical and surgical patients. J Hosp Med 4:E15-E21, 2009
13. Prandoni P, Lensing AW, Piccioli A, et al: Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100:3484-3488, 2002 (Pubitemid 35303914)
14. Decousus H, Tapson VF, Bergmann JF, et al: Factors at admission associated with bleeding risk in medical patients: Findings from the IMPROVE investigators. Chest 139:69-79, 2011
15. Khorana AA, Francis CW, Culakova E, et al: Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 110:2339-2346, 2007 (Pubitemid 350100757)
16. Timp JF, Braekkan SK, Versteeg HH, et al: Epidemiology of cancer-associated venous thrombosis. Blood 122:1712-1723, 2013
17. Lyman GH, Khorana AA, Kuderer NM, et al: Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:2189-2204, 2013
18. Cohen AT, Davidson BL, Gallus AS, et al: Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: Randomised placebo controlled trial. BMJ 332:325-329, 2006
19. Leizorovicz A, Cohen AT, Turpie AG, et al: Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 110:874-879, 2004 (Pubitemid 39096017)
20. Samama MM, Cohen AT, Darmon JY, et al: A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients: Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 341:793-800, 1999 (Pubitemid 29420474)
21. Carrier M, Khorana AA, Moretto P, et al: Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer. Am J Med 127:82-86, 2014